Most children will contract RSV by the time they turn 2 years old. These preventative tips can help limit the spread.

About 8 in 10 infants received respiratory syncytial virus protection during the 2023 to 2024 season, according to study findings.

Live-attenuated respiratory syncytial virus (RSV) vaccines are highly immunogenic among HIV-exposed uninfected (HEU) pediatric patients, according to results of a study published in Open Forum ...

RSV is a common but highly infectious respiratory virus that affects the breathing system, particularly in young children and older adults. According to the Public Health Agency, there have been more ...

Nearly 80% of infants born in a California health system were exposed to nirsevimab or the maternal respiratory syncytial ...

Flu season is here in California, but other illnesses are in full swing in the Golden State. Here are the symptoms and how ...

Symptoms: Most people, including infants, develop only mild RSV symptoms similar to that of a common cold, such as congestion ...

EDP-235 is under clinical development by Enanta Pharmaceuticals and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

Remdesivir is under clinical development by Suzhou Vigonvita Life Sciences and currently in Phase III for Coronavirus Disease 2019 (COVID-19).

China is reportedly monitoring an uptick in Human metapneumovirus (HMPV) cases, but there’s been no confirmation of a new outbreak or emergency linked to the typically mild respiratory virus.

China is reportedly monitoring an uptick in Human metapneumovirus (HMPV) cases, but there’s been no confirmation of a new outbreak or emergency linked to the typically mild respiratory virus. Photos ...